Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9428

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 0143-9428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fosaprepitant For Injection Novaplus 1)

Chemical structure diagram of fosaprepitant dimeglumine, showing the molecular composition of the active ingredient used in the injection formulation.*

FDA Label Image

Logo (Fosaprepitant For Injection Novaplus 2)

Label for Fosaprepitant for Injection 150 mg per vial, a lyophilized powder for intravenous use. It is a single-dose vial with instructions to discard any unused portion. Storage instructions specify refrigeration at 2°C to 8°C. The product is manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Logo (Fosaprepitant For Injection Novaplus 3)

Fosaprepitant for Injection 150 mg per vial carton label for sterile lyophilized powder for intravenous injection. The label states reconstitution instructions with 5 mL of 0.9% sodium chloride and warns against using solutions containing divalent cations. Manufactured by Qilu Pharmaceutical and distributed by Hikma Pharmaceuticals USA Inc. Includes NDC 0143-9428-01, barcode, active ingredients, and dosage details. Single dose vial with disposal instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.